Tianjin Chase Sun Pharmaceutical Co Ltd Financial Flexibility Index

Latest as of September 2025: 0.09x

Tianjin Chase Sun Pharmaceutical Co Ltd financial flexibility index. Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥174.88 Million (operating CF CN¥153.30 Million minus capex CN¥21.58 Million) represents 0% of total liabilities (CN¥1.96 Billion). See how much free cash does Tianjin Chase Sun Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

0.09x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥174.88 Million
Operating CF − Capex

Total Liabilities

CN¥1.96 Billion
CNY

Capital Expenditures

CN¥21.58 Million
CNY

Financial Flexibility Index of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)

Financial flexibility index of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. Historical Financial Flexibility Index trend for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. Check Tianjin Chase Sun Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Tianjin Chase Sun Pharmaceutical Co Ltd Financial Flexibility Index by Year (2006–2024)

Tianjin Chase Sun Pharmaceutical Co Ltd financial flexibility index by year from 2006 to 2024. Year-by-year free cash flow to debt coverage for Tianjin Chase Sun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Tianjin Chase Sun Pharmaceutical Co Ltd (300026) cash conversion ratio.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2024 0.44x CN¥1.05 Billion CN¥852.24 Million CN¥2.37 Billion ▼ -30.2%
2023 0.63x CN¥1.88 Billion CN¥1.53 Billion CN¥2.97 Billion ▲ +74.0%
2022 0.36x CN¥1.52 Billion CN¥745.35 Million CN¥4.17 Billion ▲ +24.3%
2021 0.29x CN¥1.07 Billion CN¥391.60 Million CN¥3.65 Billion ▲ +7.2%
2020 0.27x CN¥760.44 Million CN¥196.66 Million CN¥2.79 Billion ▼ -54.2%
2019 0.60x CN¥807.12 Million CN¥216.10 Million CN¥1.36 Billion ▼ -20.9%
2018 0.75x CN¥683.09 Million CN¥388.19 Million CN¥907.61 Million ▼ -38.5%
2017 1.22x CN¥1.13 Billion CN¥742.38 Million CN¥919.62 Million ▲ +76.1%
2016 0.69x CN¥863.60 Million CN¥448.08 Million CN¥1.24 Billion ▲ +138.7%
2015 0.29x CN¥344.35 Million CN¥121.00 Million CN¥1.18 Billion ▼ -39.3%
2014 0.48x CN¥328.31 Million CN¥149.94 Million CN¥684.85 Million ▼ -1.3%
2013 0.49x CN¥250.79 Million CN¥143.60 Million CN¥516.40 Million ▼ -46.0%
2012 0.90x CN¥373.38 Million CN¥152.21 Million CN¥415.19 Million ▲ +7.8%
2011 0.83x CN¥298.15 Million CN¥35.64 Million CN¥357.47 Million ▼ -4.5%
2010 0.87x CN¥159.14 Million CN¥46.25 Million CN¥182.14 Million ▼ -36.2%
2009 1.37x CN¥184.88 Million CN¥135.06 Million CN¥134.90 Million ▼ -0.3%
2008 1.38x CN¥126.01 Million CN¥77.74 Million CN¥91.63 Million ▲ +100.9%
2007 0.68x CN¥77.88 Million CN¥72.01 Million CN¥113.79 Million ▲ +1230.2%
2006 0.05x CN¥4.34 Million CN¥1.22 Million CN¥84.34 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities